STOCK TITAN

22nd Century Group to Present at the Virtual Fall Investor Summit on November 17

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

22nd Century Group (NYSE American: XXII) announced its participation in the Virtual Fall Investor Summit from November 16-18, 2020. The company will present on November 17 at 4:30 p.m. ET. Investors can access the live webcast and presentation through the Investors section of its website. The archived replay will be available after the event. 22nd Century focuses on tobacco harm reduction and hemp/cannabis research.

Positive
  • None.
Negative
  • None.

WILLIAMSVILLE, N.Y., Nov. 16, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will present and meet with investors at the Virtual Fall Investor Summit. The conference is being held virtually November 16 -18, 2020.

22nd Century is scheduled to present on Tuesday, November 17, 2020 at 4:30 p.m. ET. The live webcast and presentation will be accessible in the Investors section of 22nd Century’s website under Events. An archived replay of the webcast will be available shortly after the live event.

Please visit https://investorsummitgroup.com/ to register for the conference and schedule one-on-one meeting with 22nd Century.

About 22nd Century Group, Inc.

22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking through the Company’s proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The Company’s primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury and on LinkedIn.

Investor Relations & Media Contact:
Mei Kuo
Director, Communications & Investor Relations
22nd Century Group, Inc.
(716) 300-1221
mkuo@xxiicentury.com 


FAQ

When will 22nd Century Group present at the Virtual Fall Investor Summit?

22nd Century Group will present on November 17, 2020, at 4:30 p.m. ET.

How can I access the webcast of 22nd Century Group's presentation?

The webcast will be accessible in the Investors section of 22nd Century's website during the presentation.

What is the focus of 22nd Century Group?

22nd Century Group focuses on tobacco harm reduction and hemp/cannabis research.

What are the dates for the Virtual Fall Investor Summit?

The Virtual Fall Investor Summit is being held from November 16 to 18, 2020.

What is the stock symbol for 22nd Century Group?

The stock symbol for 22nd Century Group is XXII.

22nd Century Group Inc.

NASDAQ:XXII

XXII Rankings

XXII Latest News

XXII Stock Data

4.26M
38.55M
16.77%
9.82%
4.42%
Tobacco
Cigarettes
Link
United States of America
WILLIAMSVILLE